New Key Statistics Module, Z-Score and F-Score
SZSE:300158 Key Ratios
Market Cap ¥ M | 3,986.68 |
Enterprise Value ¥ M | 1,922.56 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.78 |
Price/Sales | 1.16 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 3,456.00 |
EPS (TTM) ¥ | -0.02 |
Beneish M-Score | -2.33 |
10-y EBITDA Growth Rate % | -1.20 |
5-y EBITDA Growth Rate % | 3.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -146.64 |
EV-to-EBITDA | -146.64 |
PEG | -- |
Shares Outstanding M | 1,027.49 |
Net Margin (%) | -0.59 |
Operating Margin % | -1.71 |
Pre-tax Margin (%) | -0.41 |
Quick Ratio | 3.90 |
Current Ratio | 5.34 |
ROA % (ttm) | -0.33 |
ROE % (ttm) | -0.39 |
ROIC % (ttm) | -3.31 |
Dividend Yield % | -- |
Altman Z-Score | 3.94 |
SZSE:300158 Number of Guru Trades
SZSE:300158 Volume of Guru Trades
Gurus Latest Trades with SZSE:300158
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300158 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shanxi Zhendong Pharmaceutical Co Ltd Insider Transactions
No Available Data